Biotech
> Alexza Pharma ($ALXA) promoted Edwin Kamemoto to executive vice president, R&D and quality and Lori Takahashi to vice president, pharmaceutical R&D and quality. Release
> Acasti Pharma ($ACST) announced the departure of André Godin, chief financial officer, effective immediately. Release
> Cerespir names Sophie Egholm chief operating officer. Release
> Cellular Biomedicine Group ($CBMG) appointed Dr. Scott Antonia and Guoping Fan to its scientific advisory board. Release
> Harvard Bioscience ($HBIO) appoints James Green to its board of directors and announces the retirement of Robert Dishman from the board. Release
> Otonomy ($OTIC) adds George Morrow to its board of directors. Release
> Syros Pharma appoints Jonathan Garen as chief business officer, Christopher Roberts as vice president of chemistry and early development and Colleen DeSimone as vice president of finance and controller. Release
> Tara Sadeghi joins Bio-Path ($BPTH) as director of clinical operations. Release
> Yumanity Therapeutics appoints Paulash Mohsen as chief business officer. Release
> RegenX Bio appoints Luke Beshar to its board of directors. Release (PDF)
> Invitae appointed Dr. Robert Nussbaum as its chief medical officer. Release
> La Jolla Pharmaceutical ($LJPC) brought on Dr. Lakhmir Chawla as its chief medical officer. Release
> Chen Schor joined Synta ($SNTA) as the company's CEO and director. Release
> Vic Myer joined Editas Medicine as its chief technology officer. Release
> Amicus Therapeutics ($FOLD) hired David Allsop as the senior vice president of its international division. Release
> Celsion ($CLSN) appointed Harriet Shelare as its communications director. Release
> Centene brought on Dr. Ken Yamaguchi as its chief medical officer. Release
> BioScrip named Jeffrey Kreger its chief financial officer. Release
> Neos Therapeutics hired Thomas McDonnell as its chief commercial officer. Release
> Endo International appointed Matthew Maletta as its chief legal officer. Release
> Jeff Goater moved up to the position of senior vice president of finance and business development at 2014 Fierce 15 company Voyager Therapeutics. Release
> TxCell appointed Stéphane Boissel as its CEO and also promoted Dr. Miguel Forte to chief operating officer. Release
> Dr. Joseph Sarret joined Corium International as its chief business officer. Release
> Stephen Farr joined Zogenix ($ZGNX) as the company's new CEO. Release
Pharma
> Shire ($SHPG) appoints Jeff Poulton as chief financial officer. He also joins the board of directors. Release
Drug Delivery
> BioDelivery Sciences International ($BDSI) appointed Dr. Sarah Derossett as its vice president of clinical research and medical affairs. Release
|